Vertex Pharmaceuticals (VRTX) Current Leases (2012 - 2018)
Vertex Pharmaceuticals (VRTX) posted quarterly Current Leases of $9.8 million for Q4 2018, down 56.43% year-over-year from $22.5 million in Q4 2017, and down 14.72% quarter-over-quarter from $11.5 million in Q3 2018.
Vertex Pharmaceuticals (VRTX) Current Leases (2012 - 2018) Analysis & Trends
Vertex Pharmaceuticals' Current Leases history runs 7 years deep, the most recent figure standing at $9.8 million for Q4 2018.
- In Q4 2018, Current Leases fell 56.43% year-over-year to $9.8 million; the TTM figure through Dec 2018 stood at $9.8 million (down 56.43% YoY), while the FY2018 annual figure was $9.8 million, down 56.43% from the prior year.
- Current Leases for Q4 2018 stood at $9.8 million, down from $11.5 million in the prior quarter.
- The five-year high for Current Leases was $22.5 million in Q4 2017, with the low at $9.8 million in Q4 2018.
- The 5-year median for Current Leases is $17.8 million (2014), against an average of $17.1 million.
- The sharpest annual moves came in 2014 and 2018: Current Leases jumped 120.71% in 2014, then tumbled 56.43% in 2018.
- Vertex Pharmaceuticals' Current Leases stood at $17.8 million in 2014, then retreated by 12.7% to $15.5 million in 2015, then increased by 24.97% to $19.4 million in 2016, then climbed by 15.98% to $22.5 million in 2017, then sank by 56.43% to $9.8 million in 2018.
- Business Quant data shows VRTX's Current Leases at $9.8 million in Q4 2018, $11.5 million in Q3 2018, and $15.1 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 12.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9.82 Mn |
| Sep 30, 2018 | 11.51 Mn |
| Jun 30, 2018 | 15.06 Mn |
| Mar 31, 2018 | 16.92 Mn |
| Dec 31, 2017 | 22.53 Mn |
| Sep 30, 2017 | 19.88 Mn |
| Jun 30, 2017 | 18.18 Mn |
| Mar 31, 2017 | 19.27 Mn |
| Dec 31, 2016 | 19.43 Mn |
| Sep 30, 2016 | 17.77 Mn |
| Jun 30, 2016 | 17.45 Mn |
| Mar 31, 2016 | 17.29 Mn |
| Dec 31, 2015 | 15.55 Mn |
| Sep 30, 2015 | 14.15 Mn |
| Jun 30, 2015 | 13.92 Mn |
| Mar 31, 2015 | 19.67 Mn |
| Dec 31, 2014 | 17.81 Mn |
| Sep 30, 2014 | 18.12 Mn |
| Jun 30, 2014 | 19.71 Mn |
| Mar 31, 2014 | 18.32 Mn |